首页> 外文期刊>Gastrointestinal Endoscopy >A multicenter randomized comparison of the Endocapsule and the Pillcam SB.
【24h】

A multicenter randomized comparison of the Endocapsule and the Pillcam SB.

机译:Endocapsule和Pillcam SB的多中心随机比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Video capsule endoscopy has been shown to be the single most effective endoscopic procedure for identifying the source of obscure GI bleeding (OGIB). OBJECTIVE: Our purpose was to report on the Food and Drug Administration pivotal trial in which the Endocapsule (EC) (Olympus America, Allentown, Pa) was compared with the Pillcam SB (PSB) (Given Imaging, Yoqneam, Israel) in patients with OGIB. DESIGN: A novel trial design was used in which the EC and the PSB were swallowed by the same patient 40 minutes apart, in randomized order. SETTING: Four academic medical centers. PATIENTS: Patients with OGIB aged 18 to 85 years who had either been transfused or who had a hematocrit of <31% in males or <28% in females. INTERVENTIONS: Both video capsules were swallowed in random order. Videos from the PSB were read locally for patient management. All videos were then read by at least 2 independent readers for normal versus abnormal categorization, a diagnosis, capsule transit time, reading time, and a subjective assessment of image quality. MAIN OUTCOME MEASUREMENT: Categorization of videos as either normal or abnormal. RESULTS: Data from 51 of 63 enrolled patients were analyzed. Nine patients were excluded for technical reasons and 3 for protocol violations. Twenty-four videos were read as normal and 14 as abnormal from both capsules. Disagreement occurred in 13. No adverse events were reported for either capsule. Overall agreement was 38 of 51 (74.5%) with a kappa of 0.48, P = .008. LIMITATIONS: Although ingestion order was randomized, the videos could not be read blind owing to a different shape of the image margin. CONCLUSIONS: (1) Both devices were safe and had a comparable diagnostic yield within the range previously reported. (2) There was a subjective difference in image quality favoring the EC. (3) This study design provided unique information about capsule movement in the small intestine and the lack of electromechanical interference between 2 different capsules.
机译:背景:视频胶囊内窥镜检查已被证明是识别隐匿性胃肠道出血(OGIB)来源的最有效的内窥镜检查方法。目的:我们的目的是报告食品和药物管理局的一项关键试验,该试验对患有以下疾病的患者进行了比较:将内毒素(EC)(美国奥林匹斯美国,宾夕法尼亚州阿伦敦)与Pillcam SB(PSB)(吉文成像,以色列约克尼姆)进行了比较OGIB。设计:采用一种新颖的试验设计,其中EC和PSB随机间隔40分钟被同一名患者吞咽。地点:四个学术医学中心。患者:年龄在18至85岁之间的OGIB患者已经输血或男性中血细胞比容低于31%,女性中血细胞比容低于28%。干预措施:两个视频胶囊均以随机顺序吞下。会从本地读取PSB的视频以进行患者管理。然后,至少2位独立阅读器会读取所有视频,以进行正常分类与异常分类,诊断,胶囊通过时间,阅读时间以及图像质量的主观评估。主要指标:将视频分类为正常或异常。结果:分析了63名入组患者中51名的数据。 9名患者由于技术原因被排除,3名因违反协议而被排除在外。从两个胶囊中读取了二十四个视频正常,而将十四个视频读取为异常。 13位患者意见分歧。总体同意率为51的38(74.5%),kappa为0.48,P = 0.008。限制:尽管摄取顺序是随机的,但由于图像边距的形状不同,因此无法盲目阅读视频。结论:(1)两种装置都是安全的,并且在先前报道的范围内具有相当的诊断率。 (2)偏爱EC的图像质量存在主观差异。 (3)该研究设计提供了有关小肠中胶囊运动的独特信息,以及2种不同胶囊之间缺乏机电干扰的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号